For decades, pharmaceutical companies have deployed an array of tactics aimed at preventing low-cost copies of their drugs from entering the marketplace.
Drugmakers use safety rule to block generics
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.